BioSpace News Archive

Business

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX, TSX-V: EPI), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal second quarter ended March 31, 2020.

May 7, 2020
·
9 min read
Business

Therapix Biosciences Appoints Prof. Ari Shamiss (M.D., M.P.A.) to the Company’s Board of Directors

Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announces today the appointment of Prof. Ari Shamiss (M.D., M.P.A.) to the Company’s Board of Directors.

May 7, 2020
·
3 min read
Validation and Reliability of COVID-19 Rapid Test BIOZEK

The validation and overall specificity of the Biozek rapid test has 98% for IgG and 96%, for IgM, which is a bench mark for antibody rapid tests. Additional research is currently being conducted in various University hospitals, including the Amsterdam University Medical Center.

May 7, 2020
·
2 min read
Pharm Country

AngioDynamics to Present at the UBS Virtual Global Healthcare Conference

AngioDynamics, Inc. announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the UBS Virtual Global Healthcare Conference at 9:10 a.m.

May 7, 2020
·
1 min read
Business

Globus Medical Reports First Quarter 2020 Results

Globus Medical, Inc., a leading musculoskeletal solutions company, announced its financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
10 min read
Business

CytomX Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update Company to Host a Conference Call Today, May 7, 2020, at 5:00 p.m. ET / 2:00 p.m. PT

CytomX Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its Probody® therapeutic technology platform, reported first quarter 2020 financial results and provides a business update.

May 7, 2020
·
12 min read
Business

Plus Therapeutics To Report First Quarter Fiscal Year 2020 Financial Results and Corporate Update on May 14, 2020

Plus Therapeutics, Inc. announced that it will report its First Quarter Fiscal Year 2020 financial results after the close of market on May 14, 2020.

May 7, 2020
·
3 min read
Business

Coherus BioSciences Reports First Quarter 2020 Financial Results

Coherus BioSciences, Inc., reviewed corporate events and reported financial results for the quarter ended March 31, 2020.

May 7, 2020
·
10 min read
Biotech Beach

Edwards Announces Updates From Annual Meeting - May 07, 2020

Edwards Lifesciences Corporation, the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced updates from its annual meeting, in which Edwards’ stockholders voted with the board’s recommendations on all proxy proposals.

May 7, 2020
·
5 min read
Business

Nektar Therapeutics Reports First Quarter 2020 Financial Results

Cash and investments in marketable securities at March 31, 2020 were approximately $1.5 billion as compared to $1.6 billion at December 31, 2019.

May 7, 2020
·
11 min read